Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2016 |  NVAX Novavax, Inc. - Common Stock | 11.00 USD | -1.96% | +3.77% | +9.45% | +23.32% | 1.81 B USD | ||
| 2021 |  ZYME Zymeworks Inc. - Common Stock | 25.24 USD | -4.86% | -2.77% | -9.24% | +42.28% | 1.79 B USD | ||
| 2026 |  XNCR Xencor, Inc. - Common Stock | 24.48 USD | +0.91% | -1.17% | -2.55% | +96.78% | 1.82 B USD | ||
| 2027 |  BHVN Biohaven Ltd. Common Shares | 11.94 USD | +0.34% | -10.70% | -17.66% | -29.52% | 1.80 B USD | ||
| 2035 |  MESO Mesoblast Limited - American Depositary Shares | 13.74 USD | -1.43% | -4.05% | -15.45% | -30.43% | 1.78 B USD | ||
| 2049 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 26.23 USD | -6.92% | -6.12% | -20.56% | -0.87% | 1.71 B USD | ||
| 2070 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 12.60 USD | +7.60% | +3.96% | +0.80% | -8.16% | 1.77 B USD | ||
| 2074 |  SEPN Septerna, Inc. - Common Stock | 36.90 USD | +2.50% | -3.02% | -0.67% | +67.65% | 1.72 B USD | ||
| 2077 |  NUVB Nuvation Bio Inc. Class A Common Stock | 4.98 USD | +2.26% | -12.01% | -23.74% | +33.87% | 1.75 B USD | ||
| 2099 |  OCUL Ocular Therapeutix, Inc. - Common Stock | 7.51 USD | +3.87% | +3.02% | -33.19% | -34.70% | 1.65 B USD | ||
| 2120 |  STOK Stoke Therapeutics, Inc. - Common Stock | 23.94 USD | -1.44% | -7.96% | -18.93% | -21.25% | 1.54 B USD | ||
| 2130 |  ABSI Absci Corporation - Common Stock | 8.93 USD | -3.15% | -16.93% | +0.45% | +115.18% | 1.53 B USD | ||
| 2132 |  QURE uniQure N.V. - Ordinary Shares | 22.52 USD | -2.68% | -3.64% | -50.73% | -62.39% | 1.56 B USD | ||
| 2135 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 15.28 USD | +2.62% | +3.59% | +3.52% | -50.73% | 1.51 B USD | ||
| 2137 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 16.90 USD | -0.76% | -7.24% | -14.73% | +2.36% | 1.51 B USD | ||
| 2143 |  INVA Innoviva, Inc. - Common Stock | 20.86 USD | -0.95% | +1.51% | -1.42% | +17.06% | 1.51 B USD | ||
| 2146 |  IMCR Immunocore Holdings plc - American Depositary Shares | 29.05 USD | -1.22% | -4.88% | -17.38% | -13.23% | 1.50 B USD | ||
| 2164 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 4.42 USD | -0.23% | -6.75% | -18.15% | -12.65% | 1.44 B USD | ||
| 2196 |  NKTR Nektar Therapeutics - Common Stock | 40.78 USD | +1.29% | -13.22% | -45.70% | -44.34% | 1.39 B USD | ||
| 2204 |  OMER Omeros Corporation - Common Stock | 19.11 USD | +1.92% | +3.47% | +0.53% | +331.38% | 1.38 B USD |
Nachrichten Biotechnology Stocks
Kymera Therapeutics: Raymond James startet Coverage mit „Outperform“-Rating
Raymond James startet Coverage für Nektar-Aktie mit "Market Perform"
Raymond James nimmt Coverage für Palisade Bio mit "Outperform" auf
Raymond James bestätigt Liquidia-Rating trotz rechtlicher Unsicherheiten
Ginkgo Bioworks gewährt NSF X-Labs Zugang zu autonomem Labor
AbCellera präsentiert Phase-1/2-Daten zu Medikamentenkandidaten gegen Menopause-Beschwerden
Quantum-Si: Nachweis von 19 Aminosäuren markiert wichtigen Meilenstein für Proteus-Plattform
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |